The delisting overhang is removed for now, but the company must execute its operational and financial plan to maintain compliance. Monitor quarterly reviews for progress on equity and profitability milestones. The stock may see a near-term relief rally, but the small $9M market cap and weak balance sheet imply high execution risk.
Price Chart
Executive Summary
Picard Medical received NYSE American acceptance of its compliance plan, avoiding immediate delisting and allowing continued trading under PMI. The company has until November 8, 2027 to meet the exchange's continued listing standards, but remains in a precarious financial position with a stockholders' deficit of $(1.4) million as of March 2026 and losses in three of the last four fiscal years.
Key Facts
- NYSE American accepted Picard Medical's compliance plan on July 22, 2026, avoiding delisting
- Compliance period runs through November 8, 2027, subject to quarterly review
- Stockholders' equity was $3.8 million as of December 31, 2025, but turned to a deficit of $(1.4) million as of March 31, 2026
- Company reported losses in three of the four most recent fiscal years ended December 31, 2025
- Original non-compliance was under Sections 1003(a)(i) and (ii) of the NYSE American Company Guide
Financial Impact
Stockholders' deficit of $(1.4) million as of March 31, 2026; no revenue or earnings data in this filing
Risk Factors
- Failure to achieve compliance milestones could result in delisting before November 2027
- Continued losses and negative equity increase the need for dilutive capital raises
- Micro-cap stock with high volatility and low institutional ownership
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-024465 |
| Exhibit: ex_992872.htm | 0001437749-26-024465 |
| Document: 0001437749-26-024465-index-headers.html | 0001437749-26-024465 |
| Document: 0001437749-26-024465-index.html | 0001437749-26-024465 |
| Document: 0001437749-26-024465.txt | 0001437749-26-024465 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K | $6.43 | awaiting T+60 | — | $6.83 (+6.22%) |
Oct 22, 2026 5d ago | S-3 | $7.37 | awaiting T+60 | — | $6.83 (+7.33%) |
Oct 6, 2026 21d ago | 8-K | $8.74 | awaiting T+60 | — | $6.83 (+21.85%) |
Jul 27, 2026 13w ago | 8-K | $0.0878 $0.2096 | ▲ +138.72% | ▲ +134.67% | $6.83 (+7679.04%) |
Jul 15, 2026 14w ago | DEFA14A | $0.1600 $0.1896 | ▲ +18.50% | ▲ +14.79% | $6.83 (+4168.75%) |
Jul 8, 2026 15w ago | DEFA14A | $0.1500 $0.0864 | ▼ −42.40% | ▼ −44.89% | $6.83 (+4453.33%) |
Jul 2, 2026 16w ago | 8-K / 425 | $0.1694 | awaiting T+60 | — | $6.83 (+3931.88%) |
Jun 29, 2026 17w ago | 8-K | $0.1559 $0.0910 | ▼ −41.63% | ▼ −45.25% | $6.83 (+4281.01%) |
Jun 2, 2026 21w ago | Press Release | $13.50 | awaiting T+60 | — | $6.83 (−49.41%) |
Jun 2, 2026 21w ago | 8-K | $13.50 | awaiting T+60 | — | $6.83 (+49.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers